Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Carter

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Oncotarget|March 22, 2018
Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatmentsCosti Alifrangis, Philip Carter, Biancastella Cereser, et al.
BMC Infectious Diseases|October 14, 2016
Comparative M-protein analysis of Streptococcus pyogenes from pharyngitis and skin infections in New Zealand: Implications for vaccine developmentDeborah A Williamson, Pierre R Smeesters, Andrew C Steer, et al.
Oncotarget|March 31, 2018
Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancyPhilip Carter, Costi Alifrangis, Biancastella Cereser, et al.
Oncotarget|February 22, 2018
Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancyPhilip Carter, Costi Alifrangis, Biancastella Cereser, et al.
Oncotarget|May 1, 2018
Molecular profiling of advanced breast cancer tumors is beneficial in assisting clinical treatment plansPhilip Carter, Costi Alifrangis, Biancastella Cereser, et al.
Oncotarget|March 31, 2018
Correction: Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?Philip Carter, Costi Alifrangis, Biancastella Cereser, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|September 26, 2009
Assigning the source of human campylobacteriosis in New Zealand: a comparative genetic and epidemiological approachPetra Mullner, Simon E F Spencer, Daniel J Wilson, et al.
Oncotarget|March 7, 2018
Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?Philip Carter, Costi Alifrangis, Biancastella Cereser, et al.
Emerging Infectious Diseases|January 9, 2015
Geographic divergence of bovine and human Shiga toxin–producing Escherichia coli O157:H7 genotypes, New ZealandPatricia Jaros, Adrian L Cookson, Donald M Campbell, et al.
Molecular Ecology|January 3, 2013
Progressive genome-wide introgression in agricultural Campylobacter coliSamuel K Sheppard, Xavier Didelot, Keith A Jolley, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Oncotarget|March 22, 2018
Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatmentsCosti Alifrangis, Philip Carter, Biancastella Cereser, et al.
BMC Infectious Diseases|October 14, 2016
Comparative M-protein analysis of Streptococcus pyogenes from pharyngitis and skin infections in New Zealand: Implications for vaccine developmentDeborah A Williamson, Pierre R Smeesters, Andrew C Steer, et al.
Oncotarget|March 31, 2018
Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancyPhilip Carter, Costi Alifrangis, Biancastella Cereser, et al.
Oncotarget|February 22, 2018
Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancyPhilip Carter, Costi Alifrangis, Biancastella Cereser, et al.
Oncotarget|May 1, 2018
Molecular profiling of advanced breast cancer tumors is beneficial in assisting clinical treatment plansPhilip Carter, Costi Alifrangis, Biancastella Cereser, et al.
Oncotarget|March 31, 2018
Correction: Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?Philip Carter, Costi Alifrangis, Biancastella Cereser, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|September 26, 2009
Assigning the source of human campylobacteriosis in New Zealand: a comparative genetic and epidemiological approachPetra Mullner, Simon E F Spencer, Daniel J Wilson, et al.
Oncotarget|March 7, 2018
Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?Philip Carter, Costi Alifrangis, Biancastella Cereser, et al.
Emerging Infectious Diseases|January 9, 2015
Geographic divergence of bovine and human Shiga toxin–producing Escherichia coli O157:H7 genotypes, New ZealandPatricia Jaros, Adrian L Cookson, Donald M Campbell, et al.
Molecular Ecology|January 3, 2013
Progressive genome-wide introgression in agricultural Campylobacter coliSamuel K Sheppard, Xavier Didelot, Keith A Jolley, et al.
Pageof 3